News

  • Feb 2024

    Applications Accepted for Research Funding through Epigenetic Therapies SPORE

    Applications are now being accepted for a pair of grants offered by the Epigenetic Therapies SPORE. These $50,000 grants are awarded through its Career Enhancement Program (CEP) and Developmental Research Program (DRP) to scientists interested in developing epigenetic therapies for the treatment of cancer.

    read more

  • Nov 2023

    High Molecular Weight DNA Now Available from Fibroblasts, iPSCs

    High molecular weight DNA (HMW DNA) samples derived from fibroblasts and induced pluripotent stem cells are now available from the National Institute of General Medical Sciences’ Human Genetic Cell Repository.

    read more

  • Oct 2023

    Coriell Institute for Medical Research - 2023 Annual Report

    Explore our 2023 Annual Report to discover the remarkable journey of the Coriell Institute for Medical Research over the past year. From the launch of the Camden Cancer Research Center to the celebration of the NIGMS Repository's 50th anniversary, this report highlights our commitment to advancing cancer research and biomedical science as a whole.

    read more

  • Apr 2023

    How Coriell’s Biobanking Logistics Team Maintains Sample Integrity

    Today at Coriell, one team is responsible for a sample’s care from beginning to end—the Biobanking Logistics team. This department manages a complex and wide range of tasks and responsibilities to ensure the samples in our care are received and stored properly, and shipped with care to researchers.

    read more

  • Feb 2023

    Rare Disease Day: FAQs for Contributing to the NIGMS Human Genetic Cell Repository

    For those affected by a rare disease, there is an accessible way to contribute to the research effort. The Human Genetic Cell Repository (HGCR), sponsored by the National Institute of General Medical Sciences (NIGMS) and hosted at the Coriell Institute, contains many thousands of cell line and DNA samples derived from tissue donations from affected people, allowing researchers to study these diseases and develop new therapies. The collection of samples representing rare diseases is always growing!

    read more

  • Feb 2023

    New iPSC Lines Added in 2022

    Dozens of induced pluripotent stem cell (iPSC) lines were added to the collections in Coriell's care last year. See a full list of new lines here.

    read more

  • Feb 2023

    Research Funding Available Through Epigenetic Therapies SPORE

    The Epigenetic Therapies SPORE offers $50,000 grants through its Career Enhancement and Developmental Research programs to scientists interested in the research of epigenetic therapies in cancer. For more information, including eligibility and award details, kindly review the Request for Applications.

    read more

  • Oct 2022

    Coriell Institute for Medical Research - 2022 Annual Report

    This past year was another of growth and impact for the Coriell Institute for Medical Research, as detailed here in our 2022 Annual Report. Key milestones and achievements were accomplished in each pillar of our mission.

    read more

  • Sep 2022

    The NIA Aging Cell Repository: A Resource to Foster Collaborations Across RCCN

    How might your aging research benefit from or contribute to the National Institute on Aging (NIA) Aging Cell Repository? A recent webinar hosted by the NIA's Research Centers Collaborative Network explored the background of the collection held at Coriell, an introduction to induced pluripotent stem cells, and and the important role the Aging Cell Repository plays in aging research today.

    read more

  • Sep 2022

    NIGMS Repository: 50 Years of Biobanking History

    First established at Coriell in 1972, this collection of cells and DNA is one of the very first at Coriell and is an extension of our founder Dr. Lewis L. Coriell’s mission: To provide scientists around the world with standardized biomaterials of the highest quality to support research.

    read more